Cargando…

Publisher Correction: Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer

Detalles Bibliográficos
Autores principales: Kim, Jun Won, Byeon, Hyung Kwon, Choi, Hong-Shik, Lee, Ik Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992193/
https://www.ncbi.nlm.nih.gov/pubmed/29880872
http://dx.doi.org/10.1038/s41598-018-26659-z
_version_ 1783329966957527040
author Kim, Jun Won
Byeon, Hyung Kwon
Choi, Hong-Shik
Lee, Ik Jae
author_facet Kim, Jun Won
Byeon, Hyung Kwon
Choi, Hong-Shik
Lee, Ik Jae
author_sort Kim, Jun Won
collection PubMed
description
format Online
Article
Text
id pubmed-5992193
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-59921932018-07-05 Publisher Correction: Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer Kim, Jun Won Byeon, Hyung Kwon Choi, Hong-Shik Lee, Ik Jae Sci Rep Publisher Correction Nature Publishing Group UK 2018-06-07 /pmc/articles/PMC5992193/ /pubmed/29880872 http://dx.doi.org/10.1038/s41598-018-26659-z Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Publisher Correction
Kim, Jun Won
Byeon, Hyung Kwon
Choi, Hong-Shik
Lee, Ik Jae
Publisher Correction: Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer
title Publisher Correction: Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer
title_full Publisher Correction: Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer
title_fullStr Publisher Correction: Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer
title_full_unstemmed Publisher Correction: Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer
title_short Publisher Correction: Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancer
title_sort publisher correction: dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for t1/t2 glottic cancer
topic Publisher Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992193/
https://www.ncbi.nlm.nih.gov/pubmed/29880872
http://dx.doi.org/10.1038/s41598-018-26659-z
work_keys_str_mv AT kimjunwon publishercorrectiondosedeescalationtothenormallarynxusingconformalradiotherapyreducestoxicitywhilemaintainingoncologicoutcomefort1t2glotticcancer
AT byeonhyungkwon publishercorrectiondosedeescalationtothenormallarynxusingconformalradiotherapyreducestoxicitywhilemaintainingoncologicoutcomefort1t2glotticcancer
AT choihongshik publishercorrectiondosedeescalationtothenormallarynxusingconformalradiotherapyreducestoxicitywhilemaintainingoncologicoutcomefort1t2glotticcancer
AT leeikjae publishercorrectiondosedeescalationtothenormallarynxusingconformalradiotherapyreducestoxicitywhilemaintainingoncologicoutcomefort1t2glotticcancer